Cytomegalovirus driven immunosenescence—An immune phenotype with or without clinical impact?

Mechanisms of Ageing and Development

Volumn 158, Issue , 2016, Pages 3-13

  Söderberg Nauclér, Cecilia ^a   Fornara, Olesja ^a   Rahbar, Afsar ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cancer; Cardiovascular diseases; Elderly; Human cytomegalovirus (CMV); Immunosenescence

Indexed keywords

ANTIVIRUS AGENT; CD28 ANTIGEN; VIRUS ANTIGEN; VIRUS PROTEIN;

ADAPTIVE IMMUNITY; BONE MARROW CELL; CANCER SUSCEPTIBILITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL LINEAGE; CELLULAR IMMUNITY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISEASE PREDISPOSITION; FUNCTIONAL DISEASE; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOPATHOLOGY; IMMUNOSENESCENCE; IMMUNOSTIMULATION; INFECTION CONTROL; INFECTION SENSITIVITY; INFLAMMATORY DISEASE; LIFESPAN; NONHUMAN; PATHOGENESIS; PERSISTENT VIRUS INFECTION; PHENOTYPE; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; VIRUS CELL INTERACTION; VIRUS LATENCY; VIRUS REACTIVATION; AGING; ANIMAL; CELL AGING; IMMUNOLOGY; NEOPLASM; PATHOLOGY; VIROLOGY;

AGING; ANIMALS; CARDIOVASCULAR DISEASES; CELLULAR SENESCENCE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; HUMANS; NEOPLASMS;

EID: 84977134577     PISSN: 00476374     EISSN: 18726216     Source Type: Journal    
DOI: 10.1016/j.mad.2016.06.005     Document Type: Review

References (194)

1. Abdelwahab, S.F., Zakaria, Z., Sobhy, M., Rewisha, E., Mahmoud, M.A., Amer, M.A., Del Sorbo, M., Capone, S., Nicosia, A., Folgori, A., Hashem, M., El-Kamary, S.S., Hepatitis C virus-multispecific T-cell responses without viremia or seroconversion among Egyptian health care workers at high risk of infection. Clin. Vacc. Immunol. 19 (2012), 780–786.
2. Ahlfors, K., IgG antibodies to cytomegalovirus in a normal urban Swedish population. Scand. J. Infect. Dis. 16 (1984), 335–337.
3. Alcendor, D.J., Charest, A.M., Zhu, W.Q., Vigil, H.E., Knobel, S.M., Infection and upregulation of proinflammatory cytokines in human brain vascular pericytes by human cytomegalovirus. J. Neuroinflamm., 9, 2012, 95.
4. Appay, V., Dunbar, P.R., Callan, M., Klenerman, P., Gillespie, G.M., Papagno, L., Ogg, G.S., King, A., Lechner, F., Spina, C.A., Little, S., Havlir, D.V., Richman, D.D., Gruener, N., Pape, G., Waters, A., Easterbrook, P., Salio, M., Cerundolo, V., McMichael, A.J., Rowland-Jones, S.L., Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat. Med. 8 (2002), 379–385.
5. Atabani, S.F., Smith, C., Atkinson, C., Aldridge, R.W., Rodriguez-Peralvarez, M., Rolando, N., Harber, M., Jones, G., O'Riordan, A., Burroughs, A.K., Thorburn, D., O'Beirne, J., Milne, R.S., Emery, V.C., Griffiths, P.D., Cytomegalovirus replication kinetics in solid organ transplant recipients managed by preemptive therapy. Am. J. Transplant. 12 (2012), 2457–2464.
6. Baillie, J., Sahlender, D.A., Sinclair, J.H., Human cytomegalovirus infection inhibits tumor necrosis factor alpha (TNF-alpha) signaling by targeting the 55-kilodalton TNF-alpha receptor. J. Virol. 77 (2003), 7007–7016.
7. Barron, M.A., Gao, D., Springer, K.L., Patterson, J.A., Brunvand, M.W., McSweeney, P.A., Zeng, C., Baron, A.E., Weinberg, A., Relationship of reconstituted adaptive and innate cytomegalovirus (CMV)-specific immune responses with CMV viremia in hematopoietic stem cell transplant recipients. Clin. Infect. Dis. 49 (2009), 1777–1783.
8. Baryawno, N., Rahbar, A., Wolmer-Solberg, N., Taher, C., Odeberg, J., Darabi, A., Khan, Z., Sveinbjornsson, B., FuskevAg, O.M., Segerstrom, L., Nordenskjold, M., Siesjo, P., Kogner, P., Johnsen, J.I., Soderberg-Naucler, C., Detection of human cytomegalovirus in medulloblastomas reveals a potential therapeutic target. J. Clin. Invest. 121 (2011), 4043–4055.
9. Bayer, C., Varani, S., Wang, L., Walther, P., Zhou, S., Straschewski, S., Bachem, M., Soderberg-Naucler, C., Mertens, T., Frascaroli, G., Human cytomegalovirus infection of M1 and M2 macrophages triggers inflammation and autologous T-cell proliferation. J. Virol. 87 (2013), 67–79.
10. Benard, M., Straat, K., Omarsdottir, S., Leghmari, K., Bertrand, J., Davrinche, C., Duga-Neulat, I., Soderberg-Naucler, C., Rahbar, A., Casper, C., Human cytomegalovirus infection induces leukotriene B4 and 5-lipoxygenase expression in human placentae and umbilical vein endothelial cells. Placenta 35 (2014), 345–350.
11. Bianchi, E., Roncarati, P., Hougrand, O., Guerin-El Khourouj, V., Boreux, R., Kroonen, J., Martin, D., Robe, P., Rogister, B., Delvenne, P., Deprez, M., Human cytomegalovirus and primary intracranial tumors: frequency of tumor infection and lack of correlation with systemic immune anti-viral responses. Neuropathol. Appl. Neurobiol., 2014.
12. Biron, C.A., Byron, K.S., Sullivan, J.L., Severe herpesvirus infections in an adolescent without natural killer cells. N. Engl. J. Med. 320 (1989), 1731–1735.
13. Bodaghi, B., Jones, T.R., Zipeto, D., Vita, C., Sun, L., Laurent, L., Arenzana-Seisdedos, F., Virelizier, J.L., Michelson, S., Chemokine sequestration by viral chemoreceptors as a novel viral escape strategy: withdrawal of chemokines from the environment of cytomegalovirus-infected cells. J. Exp. Med. 188 (1998), 855–866.
14. Boppana, S.B., Rivera, L.B., Fowler, K.B., Mach, M., Britt, W.J., Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. N. Engl. J. Med. 344 (2001), 1366–1371.
15. Britt, W.J., Vugler, L.G., Antiviral antibody responses in mothers and their newborn infants with clinical and subclinical congenital cytomegalovirus infections. J. Infect. Dis. 161 (1990), 214–219.
16. Browne, E.P., Shenk, T., Human cytomegalovirus UL83-coded pp65 virion protein inhibits antiviral gene expression in infected cells. Proc. Natl. Acad. Sci. U.S.A. 100 (2003), 11439–11444.
17. Bryl, E., Vallejo, A.N., Weyand, C.M., Goronzy, J.J., Down-regulation of CD28 expression by TNF-alpha. J. Immunol. 167 (2001), 3231–3238.
18. Bukowski, J.F., Warner, J.F., Dennert, G., Welsh, R.M., Adoptive transfer studies demonstrating the antiviral effect of natural killer cells in vivo. J. Exp. Med., 161, 1985, 40.
19. Bunde, T., Kirchner, A., Hoffmeister, B., Habedank, D., Hetzer, R., Cherepnev, G., Proesch, S., Reinke, P., Volk, H.D., Lehmkuhl, H., Kern, F., Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells. J. Exp. Med. 201 (2005), 1031–1036.
20. Cameron, B., Galbraith, S., Li, H., Lloyd, A., investigators, H., Correlates and characteristics of hepatitis C virus-specific T-cell immunity in exposed uninfected high-risk prison inmates. J. Viral Hepat. 20 (2013), e96–106.
21. Campos, C., Pera, A., Sanchez-Correa, B., Alonso, C., Lopez-Fernandez, I., Morgado, S., Tarazona, R., Solana, R., Effect of age and CMV on NK cell subpopulations. Exp. Gerontol. 54 (2014), 130–137.
22. Cannon, M.J., Schmid, D.S., Hyde, T.B., Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev. Med. Virol. 20 (2010), 202–213.
23. Carbone, J., Sarmiento, E., Palomo, J., Fernandez-Yanez, J., Munoz, P., Bouza, E., Rodriguez-Molina, J., Lanio, N., Fernandez-Cruz, E., The potential impact of substitutive therapy with intravenous immunoglobulin on the outcome of heart transplant recipients with infections. Transplant. Proc. 39 (2007), 2385–2388.
24. Caruso, C., Buffa, S., Candore, G., Colonna-Romano, G., Dunn-Walters, D., Kipling, D., Pawelec, G., Mechanisms of immunosenescence. Immun. Ageing, 6, 2009, 10.
25. Casazza, J.P., Betts, M.R., Price, D.A., Precopio, M.L., Ruff, L.E., Brenchley, J.M., Hill, B.J., Roederer, M., Douek, D.C., Koup, R.A., Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation. J. Exp. Med. 203 (2006), 2865–2877.
26. Chen, W.H., Kozlovsky, B.F., Effros, R.B., Grubeck-Loebenstein, B., Edelman, R., Sztein, M.B., Vaccination in the elderly: an immunological perspective. Trends Immunol. 30 (2009), 351–359.
27. Chidrawar, S., Khan, N., Wei, W., McLarnon, A., Smith, N., Nayak, L., Moss, P., Cytomegalovirus-seropositivity has a profound influence on the magnitude of major lymphoid subsets within healthy individuals. Clin. Exp. Immunol. 155 (2009), 423–432.
28. Chiuppesi, F., Wussow, F., Johnson, E., Bian, C., Zhuo, M., Rajakumar, A., Barry, P.A., Britt, W.J., Chakraborty, R., Diamond, D.J., Vaccine-derived neutralizing antibodies to the human cytomegalovirus gH/gL pentamer potently block primary cytotrophoblast infection. J. Virol., 2015.
29. Clerici, M., Levin, J.M., Kessler, H.A., Harris, A., Berzofsky, J.A., Landay, A.L., Shearer, G.M., HIV-specific T-helper activity in seronegative health care workers exposed to contaminated blood. JAMA 271 (1994), 42–46.
30. Cobbold, M., Khan, N., Pourgheysari, B., Tauro, S., McDonald, D., Osman, H., Assenmacher, M., Billingham, L., Steward, C., Crawley, C., Olavarria, E., Goldman, J., Chakraverty, R., Mahendra, P., Craddock, C., Moss, P.A., Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers. J. Exp. Med. 202 (2005), 379–386.
31. Cobbs, C.S., Harkins, L., Samanta, M., Gillespie, G.Y., Bharara, S., King, P.H., Nabors, L.B., Cobbs, C.G., Britt, W.J., Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res. 62 (2002), 3347–3350.
32. Dechanet, J., Merville, P., Berge, F., Bone-Mane, G., Taupin, J.L., Michel, P., Joly, P., Bonneville, M., Potaux, L., Moreau, J.F., Major expansion of gammadelta T lymphocytes following cytomegalovirus infection in kidney allograft recipients. J. Infect. Dis. 179 (1999), 1–8.
33. Derhovanessian, E., Larbi, A., Pawelec, G., Biomarkers of human immunosenescence: impact of Cytomegalovirus infection. Curr. Opin. Immunol. 21 (2009), 440–445.
34. DesJardin, J.A., Gibbons, L., Cho, E., Supran, S.E., Falagas, M.E., Werner, B.G., Snydman, D.R., Human herpesvirus 6 reactivation is associated with cytomegalovirus infection and syndromes in kidney transplant recipients at risk for primary cytomegalovirus infection. J. Infect. Dis. 178 (1998), 1783–1786.
35. Dumitriu, I.E., Araguas, E.T., Baboonian, C., Kaski, J.C., CD4+ CD28 null T cells in coronary artery disease: when helpers become killers. Cardiovasc. Res. 81 (2009), 11–19.
36. Dunn, W., Chou, C., Li, H., Hai, R., Patterson, D., Stolc, V., Zhu, H., Liu, F., Functional profiling of a human cytomegalovirus genome. Proc. Natl. Acad. Sci. U.S.A. 100 (2003), 14223–14228.
37. Dzabic, M., Rahbar, A., Yaiw, K.C., Naghibi, M., Religa, P., Fellstrom, B., Larsson, E., Soderberg-Naucler, C., Intragraft cytomegalovirus protein expression is associated with reduced renal allograft survival. Clin. Infect. Dis. 53 (2011), 969–976.
38. Dziurzynski, K., Chang, S.M., Heimberger, A.B., Kalejta, R.F., McGregor Dallas, S.R., Smit, M., Soroceanu, L., Cobbs, C.S., Hcmv Gliomas, S., Consensus on the role of human cytomegalovirus in glioblastoma. Neuro Oncol. 14 (2012), 246–255.
39. Effros, R.B., Role of T lymphocyte replicative senescence in vaccine efficacy. Vaccine 25 (2007), 599–604.
40. Elkington, R., Walker, S., Crough, T., Menzies, M., Tellam, J., Bharadwaj, M., Khanna, R., Ex vivo profiling of CD8+-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers. J. Virol. 77 (2003), 5226–5240.
41. Fasth, A.E., Dastmalchi, M., Rahbar, A., Salomonsson, S., Pandya, J.M., Lindroos, E., Nennesmo, I., Malmberg, K.J., Soderberg-Naucler, C., Trollmo, C., Lundberg, I.E., Malmstrom, V., T cell infiltrates in the muscles of patients with dermatomyositis and polymyositis are dominated by CD28null T cells. J. Immunol. 183 (2009), 4792–4799.
42. Fasth, A.E., Snir, O., Johansson, A.A., Nordmark, B., Rahbar, A., Af Klint, E., Bjorkstrom, N.K., Ulfgren, A.K., van Vollenhoven, R.F., Malmstrom, V., Trollmo, C., Skewed distribution of proinflammatory CD4 + CD28null T cells in rheumatoid arthritis. Arthritis Res. Ther., 9, 2007, R87.
43. Ferguson, F.G., Wikby, A., Maxson, P., Olsson, J., Johansson, B., Immune parameters in a longitudinal study of a very old population of Swedish people: a comparison between survivors and nonsurvivors. J. Gerontol. Series A Biol. Sci. Med. Sci. 50 (1995), B378–382.
44. Fletcher, J.M., Vukmanovic-Stejic, M., Dunne, P.J., Birch, K.E., Cook, J.E., Jackson, S.E., Salmon, M., Rustin, M.H., Akbar, A.N., Cytomegalovirus-specific CD4+ T cells in healthy carriers are continuously driven to replicative exhaustion. J. Immunol. 175 (2005), 8218–8225.
45. Fornara, O., Bartek, J. Jr., Rahbar, A., Odeberg, J., Khan, Z., Peredo, I., Hamerlik, P., Bartek, J., Stragliotto, G., Landazuri, N., Soderberg-Naucler, C., Cytomegalovirus infection induces a stem cell phenotype in human primary glioblastoma cells: prognostic significance and biological impact. Cell Death Differ., 2015.
46. Fornara, O., Odeberg, J., Wolmer Solberg, N., Tammik, C., Skarman, P., Peredo, I., Stragliotto, G., Rahbar, A., Soderberg-Naucler, C., Poor survival in glioblastoma patients is associated with early signs of immunosenescence in the CD4 T-cell compartment after surgery. Oncoimmunology, 4, 2015, e1036211.
47. Fowler, K.B., Stagno, S., Pass, R.F., Britt, W.J., Boll, T.J., Alford, C.A., The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N. Engl. J. Med. 326 (1992), 663–667.
48. Gabrylewicz, B., Mazurek, U., Ochala, A., Sliupkas-Dyrda, E., Garbocz, P., Pyrlik, A., Mroz, I., Wilczok, T., Tendera, M., Cytomegalovirus infection in acute myocardial infarction. Is there a causative relationship?. Kardiol. Pol. 59 (2003), 283–292.
49. Gamadia, L.E., Remmerswaal, E.B., Weel, J.F., Bemelman, F., van Lier, R.A., Ten Berge, I.J., Primary immune responses to human CMV: a critical role for IFN-gamma-producing CD4+ T cells in protection against CMV disease. Blood 101 (2003), 2686–2692.
50. Gamadia, L.E., Rentenaar, R.J., van Lier, R.A., ten Berge, I.J., Properties of CD4(+) T cells in human cytomegalovirus infection. Hum. Immunol. 65 (2004), 486–492.
51. Garcia de Tena, J., Manzano, L., Leal, J.C., San Antonio, E., Sualdea, V., Alvarez-Mon, M., Active Crohn's disease patients show a distinctive expansion of circulating memory CD4+CD45RO+CD28null T cells. J. Clin. Immunol. 24 (2004), 185–196.
52. Gourley, T.S., Wherry, E.J., Masopust, D., Ahmed, R., Generation and maintenance of immunological memory. Semin. Immunol. 16 (2004), 323–333.
53. Griffiths, P., Baraniak, I., Reeves, M., The pathogenesis of human cytomegalovirus. J. Pathol. 235 (2015), 288–297.
54. Griffiths, P.D., Stanton, A., McCarrell, E., Smith, C., Osman, M., Harber, M., Davenport, A., Jones, G., Wheeler, D.C., O'Beirne, J., Thorburn, D., Patch, D., Atkinson, C.E., Pichon, S., Sweny, P., Lanzman, M., Woodford, E., Rothwell, E., Old, N., Kinyanjui, R., Haque, T., Atabani, S., Luck, S., Prideaux, S., Milne, R.S., Emery, V.C., Burroughs, A.K., Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial. Lancet 377 (2011), 1256–1263.
55. Groh, V., Bruhl, A., El-Gabalawy, H., Nelson, J.L., Spies, T., Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis. Proc. Natl. Acad. Sci. U.S.A. 100 (2003), 9452–9457.
56. Haffar, O.K., Smithgall, M.D., Wong, J.G., Bradshaw, J., Linsley, P.S., Human immunodeficiency virus type 1 infection of CD4+ T cells down-regulates the expression of CD28: effect on T cell activation and cytokine production. Clin. Immunol. Immunopathol. 77 (1995), 262–270.
57. Hamann, D., Roos, M.T., van Lier, R.A., Faces and phases of human CD8 T-cell development. Immunol. Today 20 (1999), 177–180.
58. Harkins, L., Volk, A.L., Samanta, M., Mikolaenko, I., Britt, W.J., Bland, K.I., Cobbs, C.S., Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer. Lancet 360 (2002), 1557–1563.
59. Harkins, L.E., Matlaf, L.A., Soroceanu, L., Klemm, K., Britt, W.J., Wang, W., Bland, K.I., Cobbs, C.S., Detection of human cytomegalovirus in normal and neoplastic breast epithelium. Herpesviridae, 1, 2010, 8.
60. Hegde, N.R., Tomazin, R.A., Wisner, T.W., Dunn, C., Boname, J.M., Lewinsohn, D.M., Johnson, D.C., Inhibition of HLA-DR assembly, transport, and loading by human cytomegalovirus glycoprotein US3: a novel mechanism for evading major histocompatibility complex class II antigen presentation. J. Virol. 76 (2002), 10929–10941.
61. Helantera, I., Koskinen, P., Finne, P., Loginov, R., Kyllonen, L., Salmela, K., Gronhagen-Riska, C., Lautenschlager, I., Persistent cytomegalovirus infection in kidney allografts is associated with inferior graft function and survival. Transpl. Int. 19 (2006), 893–900.
62. Ho, M., Epidemiology of cytomegalovirus infections. Rev. Infect. Dis. 12:Suppl. 7 (1990), S701–710.
63. Hofmann, I., Wen, Y., Ciferri, C., Schulze, A., Fuhner, V., Leong, M., Gerber, A., Gerrein, R., Nandi, A., Lilja, A.E., Carfi, A., Laux, H., Expression of the human cytomegalovirus pentamer complex for vaccine use in a CHO system. Biotechnol. Bioeng., 2015.
64. Hooper, M., Kallas, E.G., Coffin, D., Campbell, D., Evans, T.G., Looney, R.J., Cytomegalovirus seropositivity is associated with the expansion of CD4+CD28- and CD8+CD28- T cells in rheumatoid arthritis. J. Rheumatol. 26 (1999), 1452–1457.
65. Izadi, M., Zamani, M.M., Sabetkish, N., Abolhassani, H., Saadat, S.H., Taheri, S., Dabiri, H., The probable role of cytomegalovirus in acute myocardial infarction. Jundishapur J. Microbiol., 7, 2014, e9253.
66. Jamieson, B.D., Douek, D.C., Killian, S., Hultin, L.E., Scripture-Adams, D.D., Giorgi, J.V., Marelli, D., Koup, R.A., Zack, J.A., Generation of functional thymocytes in the human adult. Immunity 10 (1999), 569–575.
67. Jones, R.P., Could cytomegalovirus causing widspread outbreaks of chronic poor heath?. Shoja, M.M., A, P.S., (eds.) Hypothesis in Clinical Medicine, 2013, Nova Science Publishers, Inc., 37–79.
68. Jonjic, S., Pavic, I., Polic, B., Crnkovic, I., Lucin, P., Koszinowski, U.H., Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus. J. Exp. Med. 179 (1994), 1713–1717.
69. Kalil, R.S., Hudson, S.L., Gaston, R.S., Determinants of cardiovascular mortality after renal transplantation: a role for cytomegalovirus?. Am. J. Transplant. 3 (2003), 79–81.
70. Kanj, S.S., Sharara, A.I., Clavien, P.A., Hamilton, J.D., Cytomegalovirus infection following liver transplantation: review of the literature. Clin. Infect. Dis. 22 (1996), 537–549.
71. Khan, N., Bruton, R., Taylor, G.S., Cobbold, M., Jones, T.R., Rickinson, A.B., Moss, P.A., Identification of cytomegalovirus-specific cytotoxic T lymphocytes in vitro is greatly enhanced by the use of recombinant virus lacking the US2 to US11 region or modified vaccinia virus Ankara expressing individual viral genes. J. Virol. 79 (2005), 2869–2879.
72. Khan, N., Hislop, A., Gudgeon, N., Cobbold, M., Khanna, R., Nayak, L., Rickinson, A.B., Moss, P.A., Herpesvirus-specific CD8 T cell immunity in old age: cytomegalovirus impairs the response to a coresident EBV infection. J. Immunol. 173 (2004), 7481–7489.
73. Khan, N., Shariff, N., Cobbold, M., Bruton, R., Ainsworth, J.A., Sinclair, A.J., Nayak, L., Moss, P.A., Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. J. Immunol. 169 (2002), 1984–1992.
74. Knight, A., Madrigal, A.J., Grace, S., Sivakumaran, J., Kottaridis, P., Mackinnon, S., Travers, P.J., Lowdell, M.W., The role of Vdelta2-negative gammadelta T cells during cytomegalovirus reactivation in recipients of allogeneic stem cell transplantation. Blood 116 (2010), 2164–2172.
75. Kotenko, S.V., Saccani, S., Izotova, L.S., Mirochnitchenko, O.V., Pestka, S., Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). Proc. Natl. Acad. Sci. U.S.A. 97 (2000), 1695–1700.
76. Kovacs, I.J., Hegedus, K., Pal, A., Pusztai, R., Production of proinflammatory cytokines by syncytiotrophoblasts infected with human cytomegalovirus isolates. Placenta 28 (2007), 620–623.
77. Le Saux, S., Weyand, C.M., Goronzy, J.J., Mechanisms of immunosenescence: lessons from models of accelerated immune aging. Ann. N. Y. Acad. Sci. 1247 (2012), 69–82.
78. Leng, S.X., Li, H., Xue, Q.L., Tian, J., Yang, X., Ferrucci, L., Fedarko, N., Fried, L.P., Semba, R.D., Association of detectable cytomegalovirus (CMV) DNA in monocytes rather than positive CMV IgG serology with elevated neopterin levels in community-dwelling older adults. Exp. Gerontol. 46 (2011), 679–684.
79. Leng, S.X., Qu, T., Semba, R.D., Li, H., Yao, X., Nilles, T., Yang, X., Manwani, B., Walston, J.D., Ferrucci, L., Fried, L.P., Margolick, J.B., Bream, J.H., Relationship between cytomegalovirus (CMV) IgG serology, detectable CMV DNA in peripheral monocytes, and CMV pp65(495–503)-specific CD8+ T cells in older adults. Age (Dordr.) 33 (2011), 607–614.
80. Li, C.R., Greenberg, P.D., Gilbert, M.J., Goodrich, J.M., Riddell, S.R., Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxis. Blood 83 (1994), 1971–1979.
81. Li, H., Weng, P., Najarro, K., Xue, Q.L., Semba, R.D., Margolick, J.B., Leng, S.X., Chronic CMV infection in older women: longitudinal comparisons of CMV DNA in peripheral monocytes, anti-CMV IgG titers, serum IL-6 levels, and CMV pp65 (NLV)-specific CD8(+) T-cell frequencies with twelve year follow-up. Exp. Gerontol. 54 (2014), 84–89.
82. Li, L., Liu, Y., Bao, Z., Chen, L., Wang, Z., Li, T., Li, H., Zhuang, D., Liu, S., Wang, X., Li, J., Analysis of CD4+CD25+Foxp3+ regulatory T cells in HIV-exposed seronegative persons and HIV-infected persons with different disease progressions. Viral Immunol. 24 (2011), 57–60.
83. Linton, P.J., Dorshkind, K., Age-related changes in lymphocyte development and function. Nat. Immunol. 5 (2004), 133–139.
84. Liuzzo, G., Biasucci, L.M., Trotta, G., Brugaletta, S., Pinnelli, M., Digianuario, G., Rizzello, V., Rebuzzi, A.G., Rumi, C., Maseri, A., Crea, F., Unusual CD4+CD28null T lymphocytes and recurrence of acute coronary events. J. Am. Coll. Cardiol. 50 (2007), 1450–1458.
85. Mehta, S.K., Stowe, R.P., Feiveson, A.H., Tyring, S.K., Pierson, D.L., Reactivation and shedding of cytomegalovirus in astronauts during spaceflight. J. Infect. Dis. 182 (2000), 1761–1764.
86. Messaoudi, I., Warner, J., Nikolich-Zugich, D., Fischer, M., Nikolich-Zugich, J., Molecular, cellular, and antigen requirements for development of age-associated T cell clonal expansions in vivo. J. Immunol. 176 (2006), 301–308.
87. Michaelis, M., Baumgarten, P., Mittelbronn, M., Driever, P.H., Doerr, H.W., Cinatl, J. Jr., Oncomodulation by human cytomegalovirus: novel clinical findings open new roads. Med. Microbiol. Immunol. 200 (2011), 1–5.
88. Michaelis, M., Doerr, H.W., Cinatl, J., The story of human cytomegalovirus and cancer: increasing evidence and open questions. Neoplasia 11 (2009), 1–9.
89. Michaelis, M., Doerr, H.W., Cinatl, J. Jr., Oncomodulation by human cytomegalovirus: evidence becomes stronger. Med. Microbiol. Immunol. 198 (2009), 79–81.
90. Miller, D.M., Rahill, B.M., Boss, J.M., Lairmore, M.D., Durbin, J.E., Waldman, J.W., Sedmak, D.D., Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway. J. Exp. Med. 187 (1998), 675–683.
91. Min, H., Montecino-Rodriguez, E., Dorshkind, K., Effects of aging on early B- and T-cell development. Immunol. Rev. 205 (2005), 7–17.
92. Mitchell, D.A., Xie, W., Schmittling, R., Learn, C., Friedman, A., McLendon, R.E., Sampson, J.H., Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma. Neuro Oncol. 10 (2008), 10–18.
93. Molbak, K., Espenhain, L., Nielsen, J., Tersago, K., Bossuyt, N., Denissov, G., Baburin, A., Virtanen, M., Fouillet, A., Sideroglou, T., Gkolfinopoulou, K., Paldy, A., Bobvos, J., van Asten, L., de Lange, M., Nunes, B., da Silva, S., Larrauri, A., Gomez, I.L., Tsoumanis, A., Junker, C., Green, H., Pebody, R., McMenamin, J., Reynolds, A., Mazick, A., Excess mortality among the elderly in European countries, December 2014–February 2015. Euro Surveill., 20, 2015.
94. Moss, P., Khan, N., CD8(+) T-cell immunity to cytomegalovirus. Hum. Immunol. 65 (2004), 456–464.
95. Muller, L., Pawelec, G., Aging and immunity—impact of behavioral intervention. Brain Behav. Immun. 39 (2014), 8–22.
96. Murphy, E., Yu, D., Grimwood, J., Schmutz, J., Dickson, M., Jarvis, M.A., Hahn, G., Nelson, J.A., Myers, R.M., Shenk, T.E., Coding potential of laboratory and clinical strains of human cytomegalovirus. Proc. Natl. Acad. Sci. U.S.A. 100 (2003), 14976–14981.
97. Namekawa, T., Snyder, M.R., Yen, J.H., Goehring, B.E., Leibson, P.J., Weyand, C.M., Goronzy, J.J., Killer cell activating receptors function as costimulatory molecules on CD4+CD28null T cells clonally expanded in rheumatoid arthritis. J. Immunol. 165 (2000), 1138–1145.
98. Nichols, W.G., Corey, L., Gooley, T., Davis, C., Boeckh, M., High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: evidence for indirect effects of primary CMV infection. J. Infect. Dis. 185 (2002), 273–282.
99. Nigro, G., Adler, S.P., La Torre, R., Best, A.M., Congenital Cytomegalovirus Collaborating G, Passive immunization during pregnancy for congenital cytomegalovirus infection. N. Engl. J. Med. 353 (2005), 1350–1362.
100. Nikolich-Zugich, J., Rudd, B.D., Immune memory and aging: an infinite or finite resource?. Curr. Opin. Immunol. 22 (2010), 535–540.
101. Noriega, V.M., Hesse, J., Gardner, T.J., Besold, K., Plachter, B., Tortorella, D., Human cytomegalovirus US3 modulates destruction of MHC class I molecules. Mol. Immunol. 51 (2012), 245–253.
102. Odeberg, J., Browne, H., Metkar, S., Froelich, C.J., Branden, L., Cosman, D., Soderberg-Naucler, C., The human cytomegalovirus protein UL16 mediates increased resistance to natural killer cell cytotoxicity through resistance to cytolytic proteins. J. Virol. 77 (2003), 4539–4545.
103. Ouyang, Q., Wagner, W.M., Zheng, W., Wikby, A., Remarque, E.J., Pawelec, G., Dysfunctional CMV-specific CD8(+) T cells accumulate in the elderly. Exp. Gerontol. 39 (2004), 607–613.
104. Pattacini, L., Murnane, P.M., Kahle, E.M., Bolton, M.J., Delrow, J.J., Lingappa, J.R., Katabira, E., Donnell, D., McElrath, M.J., Baeten, J.M., Lund, J.M., Differential regulatory T cell activity in HIV type 1-exposed seronegative individuals. AIDS Res. Hum. Retroviruses 29 (2013), 1321–1329.
105. Pawelec, G., T-cell immunity in the aging human. Haematologica 99 (2014), 795–797.
106. Pera, A., Campos, C., Corona, A., Sanchez-Correa, B., Tarazona, R., Larbi, A., Solana, R., CMV latent infection improves CD8+ T response to SEB due to expansion of polyfunctional CD57+ cells in young individuals. PLoS One, 9, 2014, e88538.
107. Pera, A., Campos, C., Lopez, N., Hassouneh, F., Alonso, C., Tarazona, R., Solana, R., Immunosenescence: implications for response to infection and vaccination in older people. Maturitas 82 (2015), 50–55.
108. Pieper, J., Johansson, S., Snir, O., Linton, L., Rieck, M., Buckner, J.H., Winqvist, O., van Vollenhoven, R., Malmstrom, V., Peripheral and site-specific CD4(+) CD28(null) T cells from rheumatoid arthritis patients show distinct characteristics. Scand. J. Immunol. 79 (2014), 149–155.
109. Pita-Lopez, M.L., Gayoso, I., DelaRosa, O., Casado, J.G., Alonso, C., Munoz-Gomariz, E., Tarazona, R., Solana, R., Effect of ageing on CMV-specific CD8 T cells from CMV seropositive healthy donors. Immun. Ageing, 6, 2009, 11.
110. Poirier, N., Haudebourg, T., Brignone, C., Dilek, N., Hervouet, J., Minault, D., Coulon, F., de Silly, R.V., Triebel, F., Blancho, G., Vanhove, B., Antibody-mediated depletion of lymphocyte-activation gene-3 (LAG-3(+))-activated T lymphocytes prevents delayed-type hypersensitivity in non-human primates. Clin. Exp. Immunol. 164 (2011), 265–274.
111. Potena, L., Grigioni, F., Magnani, G., Branzi, A., Prophylaxis versus preemptive therapy for prevention of the consequences of cytomegalovirus infection in transplant recipients: a still unresolved issue. Transplantation 87 (2009), 305–306 author reply 306–307.
112. Potena, L., Grigioni, F., Magnani, G., Lazzarotto, T., Musuraca, A.C., Ortolani, P., Coccolo, F., Fallani, F., Russo, A., Branzi, A., Prophylaxis versus preemptive anti-cytomegalovirus approach for prevention of allograft vasculopathy in heart transplant recipients. J. Heart Lung Transplant. 28 (2009), 461–467.
113. Potena, L., Valantine, H.A., Cytomegalovirus-associated allograft rejection in heart transplant patients. Curr. Opin. Infect. Dis. 20 (2007), 425–431.
114. Prosch, S., Heine, A.K., Volk, H.D., Kruger, D.H., CCAAT/enhancer-binding proteins alpha and beta negatively influence the capacity of tumor necrosis factor alpha to up-regulate the human cytomegalovirus IE1/2 enhancer/promoter by nuclear factor kappaB during monocyte differentiation. J. Biol. Chem. 276 (2001), 40712–40720.
115. Prosch, S., Staak, K., Stein, J., Liebenthal, C., Stamminger, T., Volk, H.D., Kruger, D.H., Stimulation of the human cytomegalovirus IE enhancer/promoter in HL-60 cells by TNFalpha is mediated via induction of NF-kappaB. Virology 208 (1995), 197–206.
116. Prosch, S., Wendt, C.E., Reinke, P., Priemer, C., Oppert, M., Kruger, D.H., Volk, H.D., Docke, W.D., A novel link between stress and human cytomegalovirus (HCMV) infection: sympathetic hyperactivity stimulates HCMV activation. Virology 272 (2000), 357–365.
117. Pulliam, L., Moore, D., West, D.C., Human cytomegalovirus induces IL-6 and TNF alpha from macrophages and microglial cells: possible role in neurotoxicity. J. Neurovirol. 1 (1995), 219–227.
118. Qiu, H., Straat, K., Rahbar, A., Wan, M., Soderberg-Naucler, C., Haeggstrom, J.Z., Human CMV infection induces 5-lipoxygenase expression and leukotriene B4 production in vascular smooth muscle cells. J. Exp. Med. 205 (2008), 19–24.
119. Raanani, P., Gafter-Gvili, A., Paul, M., Ben-Bassat, I., Leibovici, L., Shpilberg, O., Immunoglobulin prophylaxis in hematopoietic stem cell transplantation: systematic review and meta-analysis. J. Clin. Oncol. 27 (2009), 770–781.
120. Raasveld, M.H., Bloemena, E., Wilmink, J.M., Surachno, S., Schellekens, P.T., ten Berge, R.J., Interleukin-6 and neopterin in renal transplant recipients: a longitudinal study. Transpl. Int. 6 (1993), 89–94.
121. Rahbar, A., Peredo, I., Solberg, N.W., Taher, C., Dzabic, M., Xu, X., Skarman, P., Fornara, O., Tammik, C., Yaiw, K., Wilhelmi, V., Assinger, A., Stragliotto, G., Soderberg-Naucler, C., Discordant humoral and cellular immune responses to (CMV) in glioblastoma patients whose tumors are positive for CMV. Oncoimmunology, 4, 2015, e982391.
122. Rahbar, A., Stragliotto, G., Orrego, A., Peredo, I., Taher, C., Willems, J., Soderberg-Naucler, C., Low levels of human cytomegalovirus infection in Glioblastoma multiforme associates with patient survival; −a case-control study. Herpesviridae, 3, 2012, 3.
123. Razonable, R.R., Humar, A., Practice, A.S.T.I.D.C.o., Cytomegalovirus in solid organ transplantation. Am. J. Transplant. 13:Suppl. 4 (2013), 93–106.
124. Reeves, M., Sinclair, J., Aspects of human cytomegalovirus latency and reactivation. Curr. Top. Microbiol. Immunol. 325 (2008), 297–313.
125. Reeves, M., Sissons, P., Sinclair, J., Reactivation of human cytomegalovirus in dendritic cells. Discov. Med. 5 (2005), 170–174.
126. Reeves, M.B., MacAry, P.A., Lehner, P.J., Sissons, J.G., Sinclair, J.H., Latency, chromatin remodeling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers. Proc. Natl. Acad. Sci. U.S.A. 102 (2005), 4140–4145.
127. Rizzello, V., Liuzzo, G., Brugaletta, S., Rebuzzi, A., Biasucci, L.M., Crea, F., Modulation of CD4(+)CD28null T lymphocytes by tumor necrosis factor-alpha blockade in patients with unstable angina. Circulation 113 (2006), 2272–2277.
128. Rowland-Jones, S., Sutton, J., Ariyoshi, K., Dong, T., Gotch, F., McAdam, S., Whitby, D., Sabally, S., Gallimore, A., Corrah, T., et al. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nat. Med. 1 (1995), 59–64.
129. Rowland-Jones, S.L., McMichael, A., Immune responses in HIV-exposed seronegatives: have they repelled the virus?. Curr. Opin. Immunol. 7 (1995), 448–455.
130. Rubin, R.H., The pathogenesis and clinical management of cytomegalovirus infection in the organ transplant recipient: the end of the ‘silo hypothesis’. Curr. Opin. Infect. Dis. 20 (2007), 399–407.
131. Samanta, M., Harkins, L., Klemm, K., Britt, W.J., Cobbs, C.S., High prevalence of human cytomegalovirus in prostatic intraepithelial neoplasia and prostatic carcinoma. J. Urol. 170 (2003), 998–1002.
132. Savva, G.M., Pachnio, A., Kaul, B., Morgan, K., Huppert, F.A., Brayne, C., Moss, P.A., Medical Research Council Cognitive F. Ageing S, Cytomegalovirus infection is associated with increased mortality in the older population. Aging Cell 12 (2013), 381–387.
133. Scheper, W., van Dorp, S., Kersting, S., Pietersma, F., Lindemans, C., Hol, S., Heijhuurs, S., Sebestyen, Z., Grunder, C., Marcu-Malina, V., Marchant, A., Donner, C., Plachter, B., Vermijlen, D., van Baarle, D., Kuball, J., gammadeltaT cells elicited by CMV reactivation after allo-SCT cross-recognize CMV and leukemia. Leukemia 27 (2013), 1328–1338.
134. Schmidt, D., Goronzy, J.J., Weyand, C.M., CD4+ CD7− CD28− T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity. J. Clin. Invest. 97 (1996), 2027–2037.
135. Schmidt, D., Martens, P.B., Weyand, C.M., Goronzy, J.J., The repertoire of CD4+ CD28- T cells in rheumatoid arthritis. Mol. Med. 2 (1996), 608–618.
136. Schwanninger, A., Weinberger, B., Weiskopf, D., Herndler-Brandstetter, D., Reitinger, S., Gassner, C., Schennach, H., Parson, W., Wurzner, R., Grubeck-Loebenstein, B., Age-related appearance of a CMV-specific high-avidity CD8+ T cell clonotype which does not occur in young adults. Immun. Ageing, 5, 2008, 14.
137. Serriari, N.E., Gondois-Rey, F., Guillaume, Y., Remmerswaal, E.B., Pastor, S., Messal, N., Truneh, A., Hirsch, I., van Lier, R.A., Olive, D., B and T lymphocyte attenuator is highly expressed on CMV-specific T cells during infection and regulates their function. J. Immunol. 185 (2010), 3140–3148.
138. Sester, M., Gartner, B.C., Sester, U., Girndt, M., Mueller-Lantzsch, N., Kohler, H., Is the cytomegalovirus serologic status always accurate: a comparative analysis of humoral and cellular immunity. Transplantation 76 (2003), 1229–1230.
139. Sester, U., Presser, D., Dirks, J., Gartner, B.C., Kohler, H., Sester, M., PD-1 expression and IL-2 loss of cytomegalovirus- specific T cells correlates with viremia and reversible functional anergy. Am. J. Transplant. 8 (2008), 1486–1497.
140. Shellam, G.R., Allan, J.E., Papadimitriou, J.M., Bancroft, G.J., Increased susceptibility to cytomegalovirus infection in beige mutant mice. Proc. Natl. Acad. Sci. U.S.A. 78 (1981), 5104–5108.
141. Shukla, T., Singh, S., Loftus, E.V. Jr., Bruining, D.H., McCurdy, J.D., Antiviral therapy in steroid-refractory ulcerative colitis with cytomegalovirus: systematic review and meta-analysis. Inflamm. Bowel Dis., 2015.
142. Sinclair, J., Chromatin structure regulates human cytomegalovirus gene expression during latency, reactivation and lytic infection. Biochim. Biophys. Acta 1799 (2010), 286–295.
143. Slinger, E., Maussang, D., Schreiber, A., Siderius, M., Rahbar, A., Fraile-Ramos, A., Lira, S.A., Soderberg-Naucler, C., Smit, M.J., HCMV-encoded chemokine receptor US28 mediates proliferative signaling through the IL-6-STAT3 axis. Sci. Signal., 3, 2010, ra58.
144. Snyder, C.M., Cho, K.S., Bonnett, E.L., Allan, J.E., Hill, A.B., Sustained CD8+ T cell memory inflation after infection with a single-cycle cytomegalovirus. PLoS Pathog., 7, 2011, e1002295.
145. Snyder, C.M., Loewendorf, A., Bonnett, E.L., Croft, M., Benedict, C.A., Hill, A.B., CD4+ T cell help has an epitope-dependent impact on CD8+ T cell memory inflation during murine cytomegalovirus infection. J. Immunol. 183 (2009), 3932–3941.
146. Söderberg Naucler, C., Human cytomegalovirus persists in its host and attacks and avoids elimination by the immune system. Crit. Rev. Immunol. 26:3 (2006), 231–264.
147. Soderberg-Naucler, C., Does cytomegalovirus play a causative role in the development of various inflammatory diseases and cancer. J. Intern. Med. 259 (2006), 219–246.
148. Soderberg-Naucler, C., HCMV microinfections in inflammatory diseases and cancer. J. Clin. Virol. 41 (2008), 218–223.
149. Soderberg-Naucler, C., Fish, K.N., Nelson, J.A., Interferon-gamma and tumor necrosis factor-alpha specifically induce formation of cytomegalovirus-permissive monocyte-derived macrophages that are refractory to the antiviral activity of these cytokines. J. Clin. Invest. 100 (1997), 3154–3163.
150. Soderberg-Naucler, C., Fish, K.N., Nelson, J.A., Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 91 (1997), 119–126.
151. Soderberg-Naucler, C., Johnsen, J.I., Cytomegalovirus infection in brain tumors: a potential new target for therapy?. Oncoimmunology 1 (2012), 739–740.
152. Soderberg-Naucler, C., Johnsen, J.I., Cytomegalovirus in human brain tumors: role in pathogenesis and potential treatment options. World J. Exp. Med. 5 (2015), 1–10.
153. Soderberg-Naucler, C., Peredo, I., Stragliotto, G., Valganciclovir in patients with glioblastoma. N. Engl. J. Med. 369 (2013), 2066–2067.
154. Soderberg-Naucler, C., Rahbar, A., Stragliotto, G., Survival in patients with glioblastoma receiving valganciclovir. N. Engl. J. Med. 369 (2013), 985–986.
155. Speir, E., Yu, Z.X., Ferrans, V.J., Huang, E.S., Epstein, S.E., Aspirin attenuates cytomegalovirus infectivity and gene expression mediated by cyclooxygenase-2 in coronary artery smooth muscle cells. Circ. Res. 83 (1998), 210–216.
156. Staras, S.A., Dollard, S.C., Radford, K.W., Flanders, W.D., Pass, R.F., Cannon, M.J., Seroprevalence of cytomegalovirus infection in the United States, 1988–1994. Clin. Infect. Dis. 43 (2006), 1143–1151.
157. Stern-Ginossar, N., Weisburd, B., Michalski, A., Le, V.T., Hein, M.Y., Huang, S.X., Ma, M., Shen, B., Qian, S.B., Hengel, H., Mann, M., Ingolia, N.T., Weissman, J.S., Decoding human cytomegalovirus. Science 338 (2012), 1088–1093.
158. Stragliotto, G., Rahbar, A., Solberg, N.W., Lilja, A., Taher, C., Orrego, A., Bjurman, B., Tammik, C., Skarman, P., Peredo, I., Soderberg-Naucler, C., Effects of valganciclovir as an add-on therapy in patients with cytomegalovirus-positive glioblastoma: a randomized, double-blind, hypothesis-generating study. Int. J. Cancer 133 (2013), 1204–1213.
159. Sund, F., Lidehall, A.K., Claesson, K., Foss, A., Totterman, T.H., Korsgren, O., Eriksson, B.M., CMV-specific T-cell immunity, viral load, and clinical outcome in seropositive renal transplant recipients: a pilot study. Clin. Transplant. 24 (2010), 401–409.
160. Sylwester, A.W., Mitchell, B.L., Edgar, J.B., Taormina, C., Pelte, C., Ruchti, F., Sleath, P.R., Grabstein, K.H., Hosken, N.A., Kern, F., Nelson, J.A., Picker, L.J., Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J. Exp. Med. 202 (2005), 673–685.
161. Taher, C., de Boniface, J., Mohammad, A.A., Religa, P., Hartman, J., Yaiw, K.C., Frisell, J., Rahbar, A., Soderberg-Naucler, C., High prevalence of human cytomegalovirus proteins and nucleic acids in primary breast cancer and metastatic sentinel lymph nodes. PLoS One, 8, 2013, e56795.
162. Taher, C., Frisk, G., Fuentes, S., Religa, P., Costa, H., Assinger, A., Vetvik, K.K., Bukholm, I.R., Yaiw, K.C., Smedby, K.E., Backlund, M., Soderberg-Naucler, C., Rahbar, A., High prevalence of human cytomegalovirus in brain metastases of patients with primary breast and colorectal cancers. Transl. Oncol. 7 (2014), 732–740.
163. Tarrant-Elorza, M., Rossetto, C.C., Pari, G.S., Maintenance and replication of the human cytomegalovirus genome during latency. Cell Host Microbe 16 (2014), 43–54.
164. Taylor-Wiedeman, J., Sissons, J.G., Borysiewicz, L.K., Sinclair, J.H., Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J. Gen. Virol. 72:Pt 9 (1991), 2059–2064.
165. Thewissen, M., Somers, V., Hellings, N., Fraussen, J., Damoiseaux, J., Stinissen, P., CD4+CD28null T cells in autoimmune disease: pathogenic features and decreased susceptibility to immunoregulation. J. Immunol. 179 (2007), 6514–6523.
166. Torti, N., Oxenius, A., T cell memory in the context of persistent herpes viral infections. Viruses 4 (2012), 1116–1143.
167. Toyoda, M., Carlos, J.B., Galera, O.A., Galfayan, K., Zhang, X., Sun, Z., Czer, L.S., Jordan, S.C., Correlation of cytomegalovirus DNA levels with response to antiviral therapy in cardiac and renal allograft recipients. Transplantation 63 (1997), 957–963.
168. Tu, W., Potena, L., Stepick-Biek, P., Liu, L., Dionis, K.Y., Luikart, H., Fearon, W.F., Holmes, T.H., Chin, C., Cooke, J.P., Valantine, H.A., Mocarski, E.S., Lewis, D.B., T-cell immunity to subclinical cytomegalovirus infection reduces cardiac allograft disease. Circulation 114 (2006), 1608–1615.
169. Ugarte-Gil, M.F., Sanchez-Zuniga, C., Gamboa-Cardenas, R.V., Aliaga-Zamudio, M., Zevallos, F., Tineo-Pozo, G., Cucho-Venegas, J.M., Mosqueira-Riveros, A., Medina, M., Perich-Campos, R.A., Alfaro-Lozano, J.L., Rodriguez-Bellido, Z., Alarcon, G.S., Pastor-Asurza, C.A., Circulating CD4+CD28null and extra-thymic CD4+CD8+ double positive T cells are independently associated with disease damage in systemic lupus erythematosus patients. Lupus, 2015.
170. Valantine, H.A., Gao, S.Z., Menon, S.G., Renlund, D.G., Hunt, S.A., Oyer, P., Stinson, E.B., Brown, B.W. Jr., Merigan, T.C., Schroeder, J.S., Impact of prophylactic immediate posttransplant ganciclovir on development of transplant atherosclerosis: a post hoc analysis of a randomized, placebo-controlled study. Circulation 100 (1999), 61–66.
171. Vallejo, A.N., CD28 extinction in human T cells: altered functions and the program of T-cell senescence. Immunol. Rev. 205 (2005), 158–169.
172. Walter, E.A., Greenberg, P.D., Gilbert, M.J., Finch, R.J., Watanabe, K.S., Thomas, E.D., Riddell, S.R., Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N. Engl. J. Med. 333 (1995), 1038–1044.
173. van de Berg, P.J., Griffiths, S.J., Yong, S.L., Macaulay, R., Bemelman, F.J., Jackson, S., Henson, S.M., ten Berge, I.J., Akbar, A.N., van Lier, R.A., Cytomegalovirus infection reduces telomere length of the circulating T cell pool. J. Immunol. 184 (2010), 3417–3423.
174. van Leeuwen, E.M., Remmerswaal, E.B., Vossen, M.T., Rowshani, A.T., Wertheim-van Dillen, P.M., van Lier, R.A., ten Berge, I.J., Emergence of a CD4+CD28− granzyme B+, cytomegalovirus-specific T cell subset after recovery of primary cytomegalovirus infection. J. Immunol. 173 (2004), 1834–1841.
175. Vanarsdall, A.L., Johnson, D.C., Human cytomegalovirus entry into cells. Curr. Opin. Virol. 2 (2012), 37–42.
176. Wang, D., Shenk, T., Human cytomegalovirus UL131 open reading frame is required for epithelial cell tropism. J. Virol. 79 (2005), 10330–10338.
177. Wang, D., Shenk, T., Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropism. Proc. Natl. Acad. Sci. U.S.A. 102 (2005), 18153–18158.
178. Wang, E.C., Moss, P.A., Frodsham, P., Lehner, P.J., Bell, J.I., Borysiewicz, L.K., CD8highCD57+ T lymphocytes in normal, healthy individuals are oligoclonal and respond to human cytomegalovirus. J. Immunol. 155 (1995), 5046–5056.
179. Wang, E.C., Taylor-Wiedeman, J., Perera, P., Fisher, J., Borysiewicz, L.K., Subsets of CD8+, CD57+ cells in normal, healthy individuals: correlations with human cytomegalovirus (HCMV) carrier status, phenotypic and functional analyses. Clin. Exp. Immunol. 94 (1993), 297–305.
180. Wang, Y., Bai, J., Li, F., Wang, H., Fu, X., Zhao, T., Xu, W., Zhang, J., Ni, B., Wu, Y., Characteristics of expanded CD4+CD28null T cells in patients with chronic hepatitis B. Immunol. Invest. 38 (2009), 434–446.
181. Warrington, K.J., Takemura, S., Goronzy, J.J., Weyand, C.M., CD4+,CD28- T cells in rheumatoid arthritis patients combine features of the innate and adaptive immune systems. Arthritis Rheum. 44 (2001), 13–20.
182. Wherry, E.J., Ahmed, R., Memory CD8 T-cell differentiation during viral infection. J. Virol. 78 (2004), 5535–5545.
183. Wikby, A., Ferguson, F., Forsey, R., Thompson, J., Strindhall, J., Lofgren, S., Nilsson, B.O., Ernerudh, J., Pawelec, G., Johansson, B., An immune risk phenotype, cognitive impairment, and survival in very late life: impact of allostatic load in Swedish octogenarian and nonagenarian humans. J. Gerontol. Series A Biol. Sci. Med. Sci. 60 (2005), 556–565.
184. Wikby, A., Johansson, B., Olsson, J., Lofgren, S., Nilsson, B.O., Ferguson, F., Expansions of peripheral blood CD8 T-lymphocyte subpopulations and an association with cytomegalovirus seropositivity in the elderly: the Swedish NONA immune study. Exp. Gerontol. 37 (2002), 445–453.
185. Wille, P.T., Wisner, T.W., Ryckman, B., Johnson, D.C., Human cytomegalovirus (HCMV) glycoprotein gB promotes virus entry in trans acting as the viral fusion protein rather than as a receptor-binding protein. mBio, 4, 2013 e00332–00313.
186. Willinger, T., Freeman, T., Hasegawa, H., McMichael, A.J., Callan, M.F., Molecular signatures distinguish human central memory from effector memory CD8T cell subsets. J. Immunol. 175 (2005), 5895–5903.
187. Wistuba-Hamprecht, K., Frasca, D., Blomberg, B., Pawelec, G., Derhovanessian, E., Age-associated alterations in gammadelta T-cells are present predominantly in individuals infected with Cytomegalovirus. Immun. Ageing, 10, 2013, 26.
188. Wolmer-Solberg, N., Baryawno, N., Rahbar, A., Fuchs, D., Odeberg, J., Taher, C., Wilhelmi, V., Milosevic, J., Mohammad, A.A., Martinsson, T., Sveinbjornsson, B., Johnsen, J.I., Kogner, P., Soderberg-Naucler, C., Frequent detection of human cytomegalovirus in neuroblastoma: a novel therapeutic target?. Int. J. Cancer 133 (2013), 2351–2361.
189. Yokoyama, Y., Fukunaga, K., Ikeuchi, H., Kamikozuru, K., Hida, N., Ohda, Y., Iimuro, M., Yoshida, K., Kikuyama, R., Kato, K., Nagase, K., Nakamura, S., Miwa, H., Matsumoto, T., The CD4+CD28null and the regulatory CD4+CD25High T-cell phenotypes in patients with ulcerative colitis during active and quiescent disease, and following colectomy. Cytokine 56 (2011), 466–470.
190. Yu, H.T., Shin, E.C., T cell immunosenescence, hypertension, and arterial stiffness. Epidemiol. Health, 36, 2014, e2014005.
191. Zal, B., Kaski, J.C., Arno, G., Akiyu, J.P., Xu, Q., Cole, D., Whelan, M., Russell, N., Madrigal, J.A., Dodi, I.A., Baboonian, C., Heat-shock protein 60-reactive CD4+CD28null T cells in patients with acute coronary syndromes. Circulation 109 (2004), 1230–1235.
192. Zelini, P., Lilleri, D., Comolli, G., Rognoni, V., Chiesa, A., Fornara, C., Locatelli, F., Meloni, F., Gerna, G., Human cytomegalovirus-specific CD4(+) and CD8(+) T-cell response determination: comparison of short-term (24 h) assays vs long-term (7-day) infected dendritic cell assay in the immunocompetent and the immunocompromised host. Clin. Immunol. 136 (2010), 269–281.
193. Zhu, H., Cong, J.P., Yu, D., Bresnahan, W.A., Shenk, T.E., Inhibition of cyclooxygenase 2 blocks human cytomegalovirus replication. Proc. Natl. Acad. Sci. U.S.A. 99 (2002), 3932–3937.
194. Zhu, J., Shearer, G.M., Marincola, F.M., Norman, J.E., Rott, D., Zou, J.P., Epstein, S.E., Discordant cellular and humoral immune responses to cytomegalovirus infection in healthy blood donors: existence of a Th1-type dominant response. Int. Immunol. 13 (2001), 785–790.